Ren, J.; Wang, X.; Yee, C.; Gorrell, M.D.; McLennan, S.V.; Twigg, S.M.
Sitagliptin Is More Effective Than Gliclazide in Preventing Pro-Fibrotic and Pro-Inflammatory Changes in a Rodent Model of Diet-Induced Non-Alcoholic Fatty Liver Disease. Molecules 2022, 27, 727.
https://doi.org/10.3390/molecules27030727
AMA Style
Ren J, Wang X, Yee C, Gorrell MD, McLennan SV, Twigg SM.
Sitagliptin Is More Effective Than Gliclazide in Preventing Pro-Fibrotic and Pro-Inflammatory Changes in a Rodent Model of Diet-Induced Non-Alcoholic Fatty Liver Disease. Molecules. 2022; 27(3):727.
https://doi.org/10.3390/molecules27030727
Chicago/Turabian Style
Ren, Jing, Xiaoyu Wang, Christine Yee, Mark D. Gorrell, Susan V. McLennan, and Stephen M. Twigg.
2022. "Sitagliptin Is More Effective Than Gliclazide in Preventing Pro-Fibrotic and Pro-Inflammatory Changes in a Rodent Model of Diet-Induced Non-Alcoholic Fatty Liver Disease" Molecules 27, no. 3: 727.
https://doi.org/10.3390/molecules27030727
APA Style
Ren, J., Wang, X., Yee, C., Gorrell, M. D., McLennan, S. V., & Twigg, S. M.
(2022). Sitagliptin Is More Effective Than Gliclazide in Preventing Pro-Fibrotic and Pro-Inflammatory Changes in a Rodent Model of Diet-Induced Non-Alcoholic Fatty Liver Disease. Molecules, 27(3), 727.
https://doi.org/10.3390/molecules27030727